Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models

被引:31
作者
Blakeney, S
Kowalski, J
Tummolo, D
DeStefano, J
Cooper, D
Guo, M
Gangolli, S
Long, D
Zamb, T
Natuk, RJ
Visalli, RJ
机构
[1] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA
[2] Wyeth Vaccines Res, Pearl River, NY 10965 USA
关键词
D O I
10.1128/JVI.79.16.10498-10506.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A herpes simplex virus type 2 (HSV-2) UL24 beta-glucuronidase (UL24-beta gluc) insertion mutant was derived from HSV-2 strain 186 via standard marker transfer techniques. Cell monolayers infected with UL24-beta gluc yielded cytopathic effect with syncytium formation. UL24-beta gluc replicated to wild-type viral titers in three different cell lines. UL24-beta gluc was not virulent after intravaginal inoculation of BALB/c mice in that all inoculated animals survived doses up to 400 times the 50% lethal dose (LD50) of the parental virus. Furthermore, few UL24-beta gluc-inoculated mice developed any vaginal lesions. Intravaginal inoculation of guinea pigs with UL24-beta gluc at a dose equivalent to the LD50 of parental virus (approximate to 5 x 10(3) PFU) was not lethal (10/10 animals survived). Although genital lesions developed in some UL24-beta gluc-inoculated guinea pigs, both the overall number of lesions and the severity of disease were far less than that observed for animals infected with parental strain 186.
引用
收藏
页码:10498 / 10506
页数:9
相关论文
共 31 条
[21]   HSV molecular biology: General aspects of herpes simplex virus molecular biology [J].
Subak-Sharpe, JH ;
Dargan, DJ .
VIRUS GENES, 1998, 16 (03) :239-251
[22]   PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF LOCUS SYN-5 IN HERPES-SIMPLEX VIRUS-1 [J].
TOGNON, M ;
GUANDALINI, R ;
ROMANELLI, MG ;
MANSERVIGI, R ;
TREVISANI, B .
VIRUS RESEARCH, 1991, 18 (2-3) :135-150
[23]   Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication [J].
Visalli, RJ ;
Fairhurst, J ;
Srinivas, S ;
Hu, W ;
Feld, B ;
DiGrandi, M ;
Curran, K ;
Ross, A ;
Bloom, JD ;
van Zeijl, M ;
Jones, TR ;
O'Connell, J ;
Cohen, JI .
JOURNAL OF VIROLOGY, 2003, 77 (04) :2349-2358
[24]   Mutation of the herpes simplex virus 1 KOSUL45 gene reveals dose dependent effects on central nervous system growth [J].
Visalli, RJ ;
Brandt, CR .
ARCHIVES OF VIROLOGY, 2002, 147 (03) :519-532
[25]   Characterization of the murine cytomegalovirus 38 kDa m137 gene product [J].
Visalli, RJ ;
Fairhurst, J ;
Kothandaraman, S ;
Buklan, A .
VIRUS RESEARCH, 2002, 84 (1-2) :181-189
[26]   A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs [J].
Wachsman, M ;
Kulka, M ;
Smith, CC ;
Aurelian, L .
VACCINE, 2001, 19 (15-16) :1879-1890
[27]   Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes [J].
Wang, KN ;
Pesnicak, L ;
Straus, SE .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7903-7910
[28]   HERPES-SIMPLEX GENES - THE BLUEPRINT OF A SUCCESSFUL HUMAN PATHOGEN [J].
WARD, PL ;
ROIZMAN, B .
TRENDS IN GENETICS, 1994, 10 (08) :267-274
[29]   CHARACTERIZATION OF THE BOVINE HERPESVIRUS-1 HOMOLOG OF THE HERPES-SIMPLEX VIRUS-1 UL24 OPEN READING FRAME [J].
WHITBECK, JC ;
LAWRENCE, WC ;
BELLO, LJ .
VIROLOGY, 1994, 200 (01) :263-270
[30]   Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latency [J].
Yoshikawa, T ;
Stanberry, LR ;
Bourne, N ;
Krause, PR .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1535-1541